PGFC
GSK icon

Peapack-Gladstone Financial Corp’s GSK GSK Stock Holding History

Peapack-Gladstone Financial Corp’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$867K Buy
15,716
+1,003
+7% +$54.4K 0.01% 409
2025
Q4 		$721K Buy
14,713
+403
+3% +$18.8K 0.01% 443
2025
Q3 		$618K Buy
14,310
+3,777
+36% +$148K 0.01% 474
2025
Q2 		$404K Sell
10,533
-3,991
-27% -$153K 0.01% 506
2025
Q1 		$563K Sell
14,524
-423
-3% -$15.5K 0.01% 462
2024
Q4 		$505K Sell
14,947
-7,258
-33% -$261K 0.01% 477
2024
Q3 		$907K Sell
22,205
-1,107
-5% -$45.3K 0.01% 404
2024
Q2 		$898K Buy
23,312
+431
+2% +$18.1K 0.01% 406
2024
Q1 		$980K Sell
22,881
-292
-1% -$12K 0.02% 399
2023
Q4 		$858K Sell
23,173
-1,441
-6% -$51.7K 0.01% 413
2023
Q3 		$892K Buy
24,614
+941
+4% +$33.4K 0.02% 401
2023
Q2 		$844K Sell
23,673
-369
-2% -$13.2K 0.02% 414
2023
Q1 		$855K Buy
24,042
+3,450
+17% +$121K 0.02% 405
2022
Q4 		$723K Sell
20,592
-7,600
-27% -$253K 0.01% 412
2022
Q3 		$829K Sell
28,192
-9,670
-26% -$366K 0.02% 390
2022
Q2 		$2.06M Sell
37,862
-92
-0.2% -$5.08K 0.05% 263
2022
Q1 		$2.07M Sell
37,954
-361
-0.9% -$19.6K 0.04% 279
2021
Q4 		$2.11M Buy
38,315
+37
+0.1% +$1.93K 0.04% 280
2021
Q3 		$1.83M Buy
38,278
+20,688
+118% +$1.04M 0.04% 291
2021
Q2 		$876K Sell
17,590
-679
-4% -$32.6K 0.02% 355
2021
Q1 		$814K Buy
18,269
+4,205
+30% +$191K 0.02% 353
2020
Q4 		$647K Buy
14,064
+222
+2% +$10.2K 0.02% 286
2020
Q3 		$651K Sell
13,842
-158
-1% -$7.92K 0.02% 254
2020
Q2 		$714K Sell
14,000
-1,371
-9% -$70.3K 0.03% 250
2020
Q1 		$728K Buy
15,371
+1,080
+8% +$57.6K 0.03% 233
2019
Q4 		$839K Sell
14,291
-393
-3% -$21.9K 0.03% 211
2019
Q3 		$783K Sell
14,684
-3,120
-18% -$161K 0.03% 217
2019
Q2 		$891K Buy
17,804
+2,960
+20% +$149K 0.04% 206
2019
Q1 		$775K Sell
14,844
-140
-0.9% -$7K 0.04% 210
2018
Q4 		$715K Sell
14,984
-44
-0.3% -$2.17K 0.04% 203
2018
Q3 		$754K Buy
15,028
+220
+1% +$11.2K 0.04% 209
2018
Q2 		$746K Sell
14,808
-160
-1% -$8.06K 0.04% 198
2018
Q1 		$731K Hold
14,968
– – 0.04% 200
2017
Q4 		$664K Buy
14,968
+5,653
+61% +$261K 0.04% 206
2017
Q3 		$473K Sell
9,315
-77
-0.8% -$3.91K 0.03% 233
2017
Q2 		$506K Buy
9,392
+92
+1% +$4.9K 0.03% 218
2017
Q1 		$490K Buy
9,300
+428
+5% +$21.7K 0.03% 221
2016
Q4 		$427K Sell
8,872
-520
-6% -$25.7K 0.03% 222
2016
Q3 		$506K Sell
9,392
-400
-4% -$21.9K 0.03% 208
2016
Q2 		$530K Sell
9,792
-771
-7% -$40.6K 0.04% 201
2016
Q1 		$535K Buy
10,563
+150
+1% +$7.47K 0.04% 203
2015
Q4 		$525K Buy
10,413
+80
+0.8% +$4.08K 0.04% 211
2015
Q3 		$497K Hold
10,333
– – 0.04% 207
2015
Q2 		$538K Sell
10,333
-545
-5% -$30.7K 0.04% 200
2015
Q1 		$628K Buy
10,878
+220
+2% +$12.6K 0.04% 192
2014
Q4 		$569K Buy
10,658
+840
+9% +$47K 0.04% 201
2014
Q3 		$564K Buy
9,818
+779
+9% +$47.8K 0.04% 190
2014
Q2 		$604K Buy
9,039
+160
+2% +$10.8K 0.05% 189
2014
Q1 		$593K Sell
8,879
-464
-5% -$31.4K 0.05% 187
2013
Q4 		$624K Buy
9,343
+464
+5% +$30.1K 0.05% 182
2013
Q3 		$557K Hold
8,879
– – 0.05% 186
2013
Q2 		$555K Buy
+8,879
New +$564K 0.05% 187

Other funds holding GSK

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
JEST
JTC Employer Solutions Trustee St Helier, Jersey $1.2B AUM 37.55% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Peapack-Gladstone Financial Corp's GSK Position: Q1 2026 in Review

Peapack-Gladstone Financial Corp increased its GSK (GSK) stake by 6.8% in Q1 2026, buying an estimated $54.4K and bringing the position to 15,716 shares worth $867K. The position accounts for 0.01% of the portfolio, ranked #409.

Peapack-Gladstone Financial Corp first reported a position in GSK in Q2 2013 and has held it in 52 quarters since. The position peaked at $2.11M in Q4 2021. 1,031 funds tracked by Wall St. Rank hold GSK as of Q1 2026.

  • Peapack-Gladstone Financial Corp held 15,716 shares of GSK worth $867K as of Q1 2026.
  • Peapack-Gladstone Financial Corp bought 1,003 GSK shares in Q1 2026, an estimated $54.4K.
  • GSK made up 0.01% of Peapack-Gladstone Financial Corp's portfolio in Q1 2026, its #409 holding.
  • Peapack-Gladstone Financial Corp first reported a position in GSK in Q2 2013 and has held it in 52 quarters since.
  • Peapack-Gladstone Financial Corp's GSK position peaked at $2.11M in Q4 2021.
  • 1,031 funds tracked by Wall St. Rank held GSK as of Q1 2026.

Based on Peapack-Gladstone Financial Corp's 13F filing for Q1 2026, filed 15 May 2026.